Where is the white space in our category?

Short answer: in hydration, the clearest gap I can see is the person on a GLP-1 medication. In the conversation I track, they say they struggle to drink enough and that most electrolyte products are too sweet for them now. Among the sources I read, none speaks to that person. That space appears open in those sources; I cannot say it is open everywhere.

What I looked at.

The websites of your six named competitors, as they stand this week. The current Amazon bestseller page for electrolyte drink mixes and the listings on it. A sample of recent reviews on the five best-selling listings. Public online conversation about GLP-1 medications and hydration that I track for your category. The consumer study you uploaded in June.

What I found.

1. 1.Claims. None of your six competitors mentions GLP-1, weight-loss medication or low-appetite use on their sites. None of the electrolyte listings on the bestseller page does either. On that page, GLP-1 claims appear on protein powders, fiber supplements and meal replacements. (Measured, site and listing copy.)
2. 2.Conversation. In the public mentions I track, GLP-1 users regularly ask what to drink for nausea, dizziness and dehydration, say they forget to drink because they are not thirsty, and describe sweet drinks, including sports drinks and flavored electrolyte mixes, as unpleasant since starting the medication. These threads have been steady over the period I have been watching. (Measured, from tracked public mentions. This is a count of what people say, not a market size.)
3. 3.Reviews. In the sample I read, 'too sweet' is the most common complaint across the top five listings, ahead of price and mixability. Some of those reviews mention a GLP-1 medication by name or say they are on a weight-loss shot. (Measured, from the sample. I did not read every review, and the sample is not weighted by sales.)
4. 4.Formats. Each of the top five listings is sold as a flavored single-serve stick. Two of your six competitors sell a low-sweetness or unflavored option, in bulk tubs only, and neither positions it for a specific user. (Measured, listings and sites.)
5. 5.Your study. The June consumer study flags 'drinks that are not too sweet' as a rising unmet need and notes a cluster of respondents who said they drink less water than they should. It did not ask about medication. (From your uploaded document.)

What I cannot see from here. Physical shelf presence, retail distribution, share, velocity, trial, how large the GLP-1 user base is among your buyers, and any brand outside the six you named and the bestseller page. If you give me retail or panel data, or more competitors to read, I will fold them in.

What I think it means.

In the sources I read, there is a hydration buyer who says they need to drink more and dislikes what is on offer, and no one is speaking to them. You already make a product that fits, your unflavored Lite formula, and you sell it in a format this person may not want: a bulk tub, when what they describe wanting is something small to sip through a bad afternoon.

What to consider next, in order.

1. 1.Widen the read before deciding. I can check the next tier of Amazon listings and any competitors you add, so you know whether anyone is already in this space.
2. 2.If the gap holds, test Lite in a single-serve stick on Amazon, positioned for low-appetite days and small sips, with no medication claim on the pack. Listing copy can speak to nausea days and not-thirsty days in plain words.
3. 3.Before that, have regulatory review any language that references GLP-1 or weight-loss medication, including in the listing. I cannot judge where that line is from here.

I can add these to your open recommendations so they stay tracked while you decide. Tell me which way you are leaning and I will build the one-page case either way.